Sunil Arora, MD
Interventional Pain Medicine · Wilmington, NCNPI 1558366385
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,741 of the $6,088 with a category attached, or 77.9%. 15 manufacturers reported payments, led by Boston Scientific at 53.8% of the total. 2025 is the largest year on record at $3,055, more than ten times the $140 reported in 2019.
Across 221 payments — averaging $27.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$1K
- SPR Therapeutics, Inc$450
- Nevro Corp.$414
- Medtronic$189
- Globus Medical$150
- plus $444 from 9 others
What the payments were for
- Travel & lodging$1,34722%
- Food & beverage$4,74178%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 91 | $3,275 |
| Abbott | 63 | $1,166 |
| SPR Therapeutics, Inc | 5 | $450 |
| Nevro Corp. | 17 | $414 |
| Medtronic(2 entities) | 15 | $189 |
| Globus Medical | 6 | $150 |
| Vertos Medical, Inc. | 7 | $129 |
| Biotronik NRO, Inc. | 4 | $89 |
| Stryker | 4 | $74 |
| Saluda Medical Americas, Inc. | 2 | $40 |
| Stimwave Technologies Incorporated | 2 | $30 |
| Painteq LLC | 2 | $30 |
| Nalu Medical, Inc. | 1 | $20 |
| Sonex Health, Inc. | 1 | $18 |
| Merz Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,433
- SPRINT PNS System$259
- Senza$117
How this compares
$6,088 in reported general payments places this provider in the 65th percentile of 45 interventional pain medicine providers in North Carolina.
See all interventional pain medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 13 | $5,233 |
| Fentanyl | 15 | $1,353 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 69 | $1,351 |
| Gabapentin | 110 | $1,259 |
| Morphine Sulfate ErMorphine Sulfate | 34 | $765 |
| Methadone Hcl | 40 | $654 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $483 |
| Oxycodone Hcl | 24 | $429 |
| Tizanidine Hcl | 38 | $328 |
| Pregabalin | 29 | $265 |
| Methocarbamol | 17 | $260 |
| Tramadol Hcl | 40 | $222 |
| Topiramate | 14 | $207 |
| Duloxetine Hcl | 11 | $168 |
| Meloxicam | 27 | $151 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Wilmington
- John KnabWilmington$9K
- Francis PecoraroWilmington$3K
- Charles DanielsWilmington$2K
- Timothy ChafinAhoskie$59K
- Robert WilsonSalisbury$37K
- John MansfieldAsheville$25K
- Erin ChaneyJacksonville$22K
- Kevin CostelloGreenville$22K
- Scott JohnstonJacksonville$20K
- Harsh GovilStatesville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.